
Immunohistochemistry of paraffin-embedded human small intestine tissue using CSB-PA640913LA01HU at dilution of 1:100
OAS1 Antibody
CSB-PA640913LA01HU
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetOAS1
Overview
- SupplierCusabio
- Product NameOAS1 Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID4938
- Target nameOAS1
- Target description2'-5'-oligoadenylate synthetase 1
- Target synonyms(2-5')oligo(A) synthase 1; 2',5'-oligo A synthetase 1; 2-5A synthase 1; 2-5A synthetase 1; 2'-5'-oligoadenylate synthase 1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa; 2'-5'-oligoisoadenylate synthetase 1; E16 (2'-5') oligo A synthetase; E18/E16; IFI-4; OIAS; OIASI
- HostRabbit
- IsotypeIgG
- Protein IDP00973
- Protein Name2'-5'-oligoadenylate synthase 1
- Scientific DescriptionInterferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes higher oligomers of 2-5-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. The secreted form displays antiviral effect against vesicular stomatitis virus (VSV), herpes simplex virus type 2 (HSV-2), and encephalomyocarditis virus (EMCV) and stimulates the alternative antiviral pathway independent of RNase L.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC41116161